Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ICCC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
8 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 7
31 filers reported a long position in ICCC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.7M | 268.1K | +3% |
| MORGAN STANLEY | $2.4M | 233.9K | +5.5% |
| RENAISSANCE TECHNOLOGIES LLC | $1.7M | 171.1K | +12.7% |
| Cresset Asset Management, LLC | $1.4M | 135.3K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $726.5K | 72.3K | +9.9% |
| DIMENSIONAL FUND ADVISORS LP | $587.4K | 58.5K | +4.3% |
| Bleichroeder LP | $502.5K | 50K | -50.8% |
| Steadtrust LLC | $456K | 45.4K | -16.6% |
| Mesirow Financial Investment Management, Inc. | $426.9K | 42.5K | Unchanged |
| CITADEL ADVISORS LLC | $407.1K | 40.5K | +13.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.